Mary Ruisi’s Email & Phone

Image of Mary Ruisi

Mary Ruisi

Senior Medical Director @ EMD Serono, Inc.

Mary Ruisi Contact Details

Location:
Greater Boston Area
Work:
Senior Medical Director @ EMD Serono, Inc.
Medical Lead (Ulocuplumab, CXCR4 inhibitor) @ Bristol-Myers Squibb
Medical Director, Immuno-Oncology Clinical Development @ Bristol-Myers Squibb
Education:
@ University of South Carolina-Columbia
About:

Medical Director, Immuno-Oncology Clinical Development @ Medical monitor for Ph 1-3 immuno-oncology clinical trials. Trial design, strategic development, protocol development, safety monitoring, leader of physician clinical discussion group, authoring responses for regulatory documents. Working with a matrix group of operations, regulatory, project management,medical affairs, commercial, access, statistics, data management, biomarkers, and clinical pharmacology. Executing on submission-related work 

Looking for a different Mary Ruisi?

Get an email address for anyone on LinkedIn with the ContactOut Chrome extension
Install the extension - it's free!

ContactOut is used by recruiters at 30% of the Fortune 500 companies

Similar Profiles to Mary Ruisi

Recruiters looking for Mary Ruisi also viewed
Most popular profiles
Related profiles
  • No profiles to display.

Looking for colleagues of Chris Shelby at Company Inc?

Image of Julie Julie Aldridge
Principal Biostatistician
Image of Sarah Sarah Turner
Company Name EMD Serono, Inc.
Image of Britt Britt Tella
Senior Clinical Trial Lead
Image of Molly Molly Jenkins
Senior Scientific Writer
Image of Andrew Andrew Paterson
Senior Vice President Global Business Franchise Neurology & Immunology
Image of Rosann Rosann MBA
Senior Director, Regulatory Affairs, Head US Marketed Product Life Cycle Management & Compliance
Image of Boyang Boyang Bian
Scientific Director, Real-World Evidence, Global Evidence & Value Development
Image of Grace Grace Simon
Director Global Regulatory Affairs CMC
Image of Chris Chris Swan
Domestic Engineer
Image of Marcis Marcis Bajars
Medical Director Immuno-Oncology